Core Viewpoint - The article discusses a class action lawsuit against UnitedHealth Group Incorporated, highlighting an investigation by the U.S. Department of Justice into the company's operations and the implications for investors [2][3]. Group 1: Class Action Details - Investors have until July 15, 2024, to file a lead plaintiff motion in the class action for those who purchased UnitedHealth stock between March 14, 2022, and February 27, 2024 [1][4]. - The lawsuit alleges that UnitedHealth made materially false and misleading statements regarding its business practices and failed to disclose significant adverse facts [3]. Group 2: Investigation and Stock Impact - On February 27, 2024, it was reported that the DOJ is investigating the relationship between UnitedHealthcare and Optum, leading to a significant drop in UnitedHealth's stock price by $27.04, or 5.1%, closing at $498.28 per share on February 28, 2024 [2]. - The investigation centers on the lack of proper firewalls between the two units, which were supposed to protect sensitive customer information [3].

Core Viewpoint - A class action securities lawsuit has been filed against UnitedHealth Group Inc. for alleged securities fraud affecting investors between March 14, 2022, and February 27, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that UnitedHealth failed to establish proper firewalls between its businesses, Optum and UnitedHealthcare, contrary to its own policies and assurances made to the court and investors [2]. - It is alleged that there was no meaningful technological separation between Optum and UnitedHealthcare, allowing for the sharing of sensitive customer information [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until July 15, 2024, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [2]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of UnitedHealth Group Inc. regarding a class action lawsuit alleging that the company failed to establish proper firewalls between its businesses, Optum and UnitedHealthcare, leading to the sharing of sensitive customer information [1][2]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from March 14, 2022, to February 27, 2024 [1]. - Allegations state that UnitedHealth made false statements and concealed the lack of proper technological separation between Optum and UnitedHealthcare, contrary to its own policies and assurances given to the court and investors [1]. - Shareholders are encouraged to register for the class action by July 15, 2024, to potentially be appointed as lead plaintiffs [2]. Group 2: Next Steps for Shareholders - Registered shareholders will be enrolled in a portfolio monitoring software to receive updates on the case [2]. - There is no cost or obligation for shareholders to participate in the class action [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of UnitedHealth Group Inc. regarding a class action lawsuit due to allegations of false statements and failure to establish proper firewalls between its businesses, Optum and UnitedHealthcare [1][2]. Group 1: Class Action Details - The class period for the lawsuit is from March 14, 2022, to February 27, 2024 [2]. - Allegations include that UnitedHealth did not create the necessary technological separation between Optum and UnitedHealthcare, leading to the sharing of sensitive customer information [2]. - Shareholders are encouraged to register for the class action by the deadline of July 15, 2024, to potentially become lead plaintiffs [3]. Group 2: Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit, fraud, and illegal business practices [4]. - The firm is dedicated to ensuring companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Company Performance - UnitedHealth Group (UNH) closed at $489.23, down 1.59% from the previous trading day, underperforming the S&P 500's gain of 0.77% [1] - The stock has decreased by 5.24% over the past month, while the Medical sector gained 1.49% and the S&P 500 increased by 3.71% [1] - The upcoming earnings release on July 16, 2024, is anticipated to show an EPS of $6.70, reflecting a 9.12% growth year-over-year, with expected quarterly revenue of $98.92 billion, up 6.48% from the previous year [1] Annual Estimates - For the annual period, earnings are projected at $27.57 per share and revenue at $398.24 billion, indicating increases of 9.75% and 7.16% respectively compared to last year [2] - Recent changes to analyst estimates are seen as indicators of the company's business outlook, with positive revisions suggesting optimism [2] Valuation Metrics - UnitedHealth Group has a Forward P/E ratio of 18.03, which is higher than the industry average of 16.13, indicating a premium valuation [3] - The PEG ratio for UNH is currently 1.44, compared to the industry average of 1.23, suggesting that the stock is priced higher relative to its projected earnings growth [3] Industry Context - The Medical - HMOs industry is ranked 71 in the Zacks Industry Rank, placing it in the top 29% of over 250 industries [4] - The Zacks Industry Rank is based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [4]

Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group Inc. for alleged misrepresentations regarding its anti-competitive practices and data security measures during the Class Period from March 14, 2022, to February 27, 2024 [1][4]. Group 1: Class Action Details - Investors who purchased UnitedHealth common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The deadline to serve as lead plaintiff in the class action is July 15, 2024, and interested parties can join the lawsuit through the provided contact information [2][5]. Group 2: Allegations Against UnitedHealth - The lawsuit claims that UnitedHealth assured investors it had implemented robust measures to prevent anti-competitive behavior and protect customer sensitive information (CSI) after its acquisition of Change Healthcare [4]. - UnitedHealth allegedly misrepresented the effectiveness of its firewalls and data-security policies, leading to artificially inflated stock prices during the Class Period [4]. Group 3: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest ever against a Chinese company [3]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of UnitedHealth Group Inc. regarding a class action lawsuit alleging that the company failed to establish proper firewalls between its businesses, Optum and UnitedHealthcare, leading to the sharing of sensitive customer information [1][2]. Group 1 - The class period for the lawsuit is from March 14, 2022, to February 27, 2024 [1]. - Allegations include that UnitedHealth made false statements and concealed the lack of meaningful technological separation between its complementary businesses, which was contrary to its own policy and assurances given to the court and investors [1]. - Shareholders are encouraged to register for the class action by July 15, 2024, to potentially be appointed as lead plaintiff [2]. Group 2 - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [3].

Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group for alleged violations of securities laws, claiming the company made false and misleading statements regarding its anti-competitive practices and data security measures [1][2]. Group 1: Lawsuit Details - The lawsuit pertains to investors who purchased UnitedHealth securities between March 14, 2022, and February 27, 2024, and encourages them to contact the Schall Law Firm before July 15, 2024 [1]. - The complaint alleges that UnitedHealth made repeated assurances about avoiding anti-competitive behavior and safeguarding customer sensitive information, which were later revealed to be false and materially misleading [2]. Group 2: Company Statements - UnitedHealth claimed to have established "robust firewall processes" and invested significant resources in data security, asserting that its policies prohibited improper sharing of customer sensitive information [2]. - The lawsuit contends that when the truth about UnitedHealth's practices became known, investors suffered damages due to the misleading public statements made by the company [2].

Company Overview - UnitedHealth Group (UNH) closed at $496.22, with a daily increase of +0.25%, underperforming the S&P 500's gain of 0.27% [1] - Over the past month, UNH shares have decreased by 3.27%, lagging behind the Medical sector's gain of 2.89% and the S&P 500's gain of 2.85% [1] Upcoming Earnings - Analysts expect UnitedHealth Group to report earnings of $6.70 per share, reflecting a year-over-year growth of 9.12% [1] - The consensus estimate for revenue is $98.92 billion, indicating a 6.48% increase from the same quarter last year [1] Full Year Projections - For the full year, earnings are projected at $27.57 per share and revenue at $398.24 billion, showing increases of +9.75% and +7.16% respectively from the previous year [2] Analyst Estimates and Market Sentiment - Recent changes to analyst estimates indicate evolving short-term business trends, with positive revisions reflecting optimism about the company's profitability [2] - The Zacks Rank system currently rates UnitedHealth Group at 3 (Hold), with a consensus EPS projection that has decreased by 0.1% in the past 30 days [3] Valuation Metrics - UnitedHealth Group has a Forward P/E ratio of 17.95, which is a premium compared to the industry's average Forward P/E of 15.86 [3] - The company has a PEG ratio of 1.44, compared to the Medical - HMOs industry's average PEG ratio of 1.24 [3] Industry Context - The Medical - HMOs industry is part of the Medical sector and holds a Zacks Industry Rank of 69, placing it in the top 28% of over 250 industries [4] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased UnitedHealth Group Inc. common stock between March 14, 2022, and February 27, 2024, about the upcoming lead plaintiff deadline of July 15, 2024, for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought UnitedHealth common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by July 15, 2024 [1][4] - The lawsuit alleges that UnitedHealth misrepresented its efforts to prevent anti-competitive behavior and protect customer sensitive information, leading to artificially inflated stock prices [3] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [2] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its success in securities class actions since 2013 [2] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [2]